Doxorubicine

DRUG3 trials

Sponsors

Lymphoma Study Association, French Innovative Leukemia Organisation, University of Cologne

Conditions

Acute Lymphoblastic LeukemiaHodgkin LymphomaUntreated T-cell Angioimmunoblastic Lymphoma

Phase 1

Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients

CompletedNCT01056679

University of CologneHodgkin Lymphoma

Start: 2010-04-30End: 2016-02-29Target: 30Updated: 2018-03-22

Phase 2

A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

CompletedNCT00169156

Lymphoma Study AssociationUntreated T-cell Angioimmunoblastic Lymphoma

Start: 2005-12-31End: 2012-11-30Updated: 2017-03-13

Liposomal Anthracyclin in the Treatment of Elderly ALL

CompletedNCT00600977

French Innovative Leukemia OrganisationAcute Lymphoblastic Leukemia

Start: 2002-03-31End: 2006-10-31Updated: 2008-06-26

Related Papers

Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring

Blood2018-11-292 citations

INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH <scp>TET</scp>2, <scp>IDH</scp>2, <scp>DNMT</scp>3<scp>A,</scp> AND <scp>RHOA</scp> MUTATIONS IN ANGIOIMMUNOBLASTIC <scp>T</scp> CELL LYMPHOMA: <scp>A LYSA</scp> STUDY

Hematological Oncology2017-06-01